SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040351
Filing Date
2023-11-13
Accepted
2023-11-13 09:00:26
Documents
33
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 375467
2 ex31-1.htm EX-31.1 11551
3 ex31-2.htm EX-31.2 11731
4 ex32-1.htm EX-32.1 5821
5 ex32-2.htm EX-32.2 6050
  Complete submission text file 0001493152-23-040351.txt   1703030

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inti-20230930.xsd EX-101.SCH 11098
7 XBRL CALCULATION FILE inti-20230930_cal.xml EX-101.CAL 21244
8 XBRL DEFINITION FILE inti-20230930_def.xml EX-101.DEF 43555
9 XBRL LABEL FILE inti-20230930_lab.xml EX-101.LAB 118496
10 XBRL PRESENTATION FILE inti-20230930_pre.xml EX-101.PRE 89125
27 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 137811
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 231395592
SIC: 2834 Pharmaceutical Preparations